Key Takeaways CAH is seeing momentum from cost discipline, pricing actions and improving volumes across its segments.MDT is benefiting from cardiac ablation growth, raised guidance and pipeline advances.ISRG and EW stand to gain from the rising adoption of robotic surgery and minimally invasive heart procedures.The MedTech industry has shown resilience and steady growth through 2025 while navigating lingering supply-chain issues, regulatory complexities and the pace of technological change. Notably, the Dow ...